Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 read with Regulation 30 of SEBI (LODR) Regulations, 2015, we hereby enclose the copies of the Notice issued for drawing attention of shareholders in respect of information regarding 29th Annual General Meeting of the Company scheduled to be held on Thursday, 24th August, 2023 through Video Conferencing in compliance with the MCA General Circular No. 20/2020 dated 5th May, 2020. The notice was published in the following newspapers on 21st July, 2023: 1. Financial Express (English Edition) 2. Mumbai Lakshadeep (Marathi Edition)
21-07-2023
Bigul

Medico Remedies Ltd - 540937 - Intimation Under Regulation 30 (Read With Part A Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations, 2015 ("Listing Regulations')

 The Board of Directors at their meeting held today approved the following: 1. Notice of the 29th Annual General Meeting of the Company; 2. Re-appointment of Mr. Haresh Mehta as Chairman & Whole-Time Director of the Company for a further period of three years subject to the approval of members; 3. Re-appointment of Mr. Rishit Mehta as Whole-Time Director of the Company for a further period of three years subject to the approval of the members and 4. Appointment of Mr. Haresh Sanghvi, Practicing Company Secretary as Secretarial Auditor of the Company to conduct Secretarial Audit for the Financial Year 2023-24.
20-07-2023
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Outcome for Intimation Under Regulation 30 (Read With Part A Of Schedule III) (Listing Obligations And Disclosure Requirements) Regulations, 2015

 The Board of Directors at its meeting held today has approved the following: 1. Notice of the 29th Annual General Meeting of the Company; 2. Re-appointment of Mr. Haresh Mehta (DIN: 01080289) as Chairman & Whole-Time Director of the Company for a further period of three years w.e.f. 17th September, 2023 to 17th September, 2026 subject to approval of members; 3. Re-apppointment of Mr. Rishit Mehta (DIN: 07121224) as Whole-Time Director of the Company for a further period of three years w.e.f. 17th September, 2023 to 17th September, 2026 subject to approval of members and 4. Appointment of Mr. Haresh Sanghvi, Practicing Company Secretary as Secretarial Auditor of the Company to conduct Secretarial Audit for Financial Year 2023-24.
20-07-2023
Bigul

Medico Remedies Ltd - 540937 - Closure of Trading Window

 Pursuant to the SEBI (Prohibition of Insider Trading ) Regulations, 2015, as amended & Company''s Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading in its securities, the ''Trading Window'' for dealing in the equity shares of the Company is closed, for all insiders, Designated Persons and their immediate relatives, from 1st July, 2023 up to the expiry of 48 hours post the date of declaration of the Unaudited Financial Results for the quarter ended 30th June, 2023.
30-06-2023
Bigul

Medico Remedies Ltd - 540937 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 Pursuant to Circular CIR/CFD/CMD1/27/2019 dated February 08, 2019 for the purpose of compliance with Regulation 24A of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the Annual Secretarial Compliance Report for the year ended 31st March, 2023.
26-05-2023
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, please find enclosed herewith Press Release about, "Medico Remedies Limited is pleased to announce its readiness to foray into ointment manufacturing segment'.
13-05-2023
Bigul

Medico Remedies Ltd - 540937 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 In compliance with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the newspaper advertisements published in Financial Express (English Edition) and in Mumbai Lakshadeep (Marathi Edition) dated 13th May, 2023 for Publication of announcement of Audited Financial Results for the quarter and year ended 31st March, 2023.
13-05-2023
Bigul

Medico Remedies Ltd - 540937 - Outcome Of Board Meeting Held Today

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 11th May, 2023 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31st March, 2023 and Audited Financial Statement for the year ended on 31st March, 2023 along with the Auditor's Report thereon. 2. The Board's Report and its annexures, Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March, 2023.
11-05-2023
Bigul

Medico Remedies Ltd - 540937 - Board Meeting Outcome for Outcome Of Board Meeting Held Today

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of our Company at their meeting held today i.e. 11th May, 2023 has, inter alia considered and approved the following: 1. Audited Standalone Financial Results of the Company for the quarter ended 31st March, 2023 and Audited Financial Statement for the year ended on 31st March, 2023 along with the Auditor's Report thereon. 2. The Board's Report and its annexures, Management Discussion Analysis (MDA) and Corporate Governance Report of the Company for the financial year ended on 31st March, 2023.
11-05-2023
Bigul

Annual report for Medico Remedies Ltd. for FY-2023
11-05-2023
Next Page
Close

Let's Open Free Demat Account